Addex Therapeutics Ltd American Depositary Shares (ADXN)
Stock · NASDAQ · Health Care
$3.84as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
About ADXN
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 3
Fundamentals
- 1-day range
- Market cap
- $7.34M
- P/E (trailing)
- —
- P/E (forward)
- -116.00
- EPS (trailing)
- $-0.06
- Dividend yield
- —
- Beta
- -0.06
- Avg. volume
- 2.5K
Addex Therapeutics Ltd American Depositary Shares Competitors
Chosen by industry and closest market cap.
- ADXNAddex Therapeutics Ltd American Depositary Shares$3.84▼ 0.26%Market cap $7.34MP/E —$0.0252$0.085
- APUSApimeds Pharmaceuticals US Inc. Common Stock$3.87▼ 1.28%Market cap $7.29MP/E —$3.39$403.1
- MTVAMetaVia Inc. Common Stock$1.71▲ 3.01%Market cap $7.49MP/E —$0.9661$19.03
- CNSPCNS Pharmaceuticals Inc. Common Stock$5.52▲ 0.11%Market cap $7.65MP/E —$1.9$10.59
- PCSAProcessa Pharmaceuticals Inc. Common Stock$2.07▼ 1.90%Market cap $7.65MP/E 3.31$1.67$14.24
- APREAprea Therapeutics Inc. Common stock$0.8387▼ 2.48%Market cap $7.83MP/E —$0.548$1.69
- IMNNImunon Inc. Common Stock$1.58▼ 1.25%Market cap $6.64MP/E —$1.47$6.35
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ADXN Addex Therapeutics Ltd American Depositary Shares | $7.34M | — | $3.84 | ▼ 0.26% | $0.0252$0.085 |
| APUS Apimeds Pharmaceuticals US Inc. Common Stock | $7.29M | — | $3.87 | ▼ 1.28% | $3.39$403.1 |
| MTVA MetaVia Inc. Common Stock | $7.49M | — | $1.71 | ▲ 3.01% | $0.9661$19.03 |
| CNSP CNS Pharmaceuticals Inc. Common Stock | $7.65M | — | $5.52 | ▲ 0.11% | $1.9$10.59 |
| PCSA Processa Pharmaceuticals Inc. Common Stock | $7.65M | 3.31 | $2.07 | ▼ 1.90% | $1.67$14.24 |
| APRE Aprea Therapeutics Inc. Common stock | $7.83M | — | $0.8387 | ▼ 2.48% | $0.548$1.69 |
| IMNN Imunon Inc. Common Stock | $6.64M | — | $1.58 | ▼ 1.25% | $1.47$6.35 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 8/21/2026
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · 8/21/2026
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga · 8/20/2026
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga · 8/4/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 8/3/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 455
- Total value held
- $2.9K
- Institutional holders
- 4
- Unknown301
- Unknown81
- Unknown72
- Unknown1
See the full, filterable feed with live charts on the MarketWall dashboard.